BIOCYBERNETICS AND BIOMEDICAL ENGINEERING, cilt.38, sa.2, ss.399-408, 2018 (SCI-Expanded)
Background and objectives Despite therapeutic advances, a complete cure has not been found yet for patients with type 1 diabetes (T1D). Artificial pancreas (AP) is a promising approach to cope with this disease The controller part of the AP can compute the insulin infusion rate that keeps blood glucose concentration (BGC) in normoglycemic ranges Most controllers rely on model-based controllers and use manual meal announcements or meal detection algorithms. For a fully automated AP, a controller only using the patient's BGC data is needed